Fiscal 2025 revenue guidance was reduced to a range of $12.5 million to $14.0 million from the prior range of $14.5 million to $16.6 million as operational challenges lasted longer than management ...

Q2 2025 Management View David A. Pace, President and CEO, stated that since stepping in as CEO, "challenges facing our business have come further into focus" and emphasized the rollout of the new ...

Gusty winds around isolated storms could turn wetter by the weekend. Afternoon temperatures hover near 90 until a possible ...

Red Robin Gourmet Burgers, Inc. ( NASDAQ: RRGB) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET David A. Pace - President, CEO & Director Todd Wilson - Executive VP & CFO ...

Extreme heat is the leading weather-related killer in the United States, with heat waves responsible for more deaths than ...

Q2 2025 Management View Andrew H. Madsen announced his decision to step down as CEO at the end of August due to health reasons, with Joe Christina, current President and COO, taking over as CEO.

Key Points Jasper Therapeutics (NASDAQ:JSPR) reported a GAAP loss per share of $1.74 for Q2 2025. Research and development expenses (GAAP) nearly doubled to $21.2 million in Q2 2025 from $11.3 million ...

TORONTO, ON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV:FW), a leading provider of flexible growth capital ...